These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 6707634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preferential adsorption of dopamine antagonist binding sites by fluphenazine-agarose.
    Fong JC.
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):113-7. PubMed ID: 3749364
    [Abstract] [Full Text] [Related]

  • 5. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 6. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM, Ramwani J, Srivastava LK, Rajakumar G, Ross GM, Cullen M, Mishra RK.
    J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
    [Abstract] [Full Text] [Related]

  • 7. Dopamine receptor of the porcine anterior pituitary gland. Solubilization and characterization.
    Kilpatrick BF, Caron MG.
    Biochem Pharmacol; 1984 Jun 15; 33(12):1981-8. PubMed ID: 6547344
    [Abstract] [Full Text] [Related]

  • 8. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X, Segawa T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):401-10. PubMed ID: 2680521
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Solubilization of striatal D-2 dopamine receptors: evidence that apparent loss during aging is not due to membrane sequestration.
    Henry JM, Roth GS.
    J Gerontol; 1986 Mar 03; 41(2):129-35. PubMed ID: 3005385
    [Abstract] [Full Text] [Related]

  • 12. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]

  • 13. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A, Seeman P.
    Biochem Pharmacol; 1987 Jul 01; 36(13):2095-9. PubMed ID: 2955789
    [Abstract] [Full Text] [Related]

  • 14. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A, Madras B, Seeman P.
    Eur J Pharmacol; 1981 Mar 26; 70(3):321-9. PubMed ID: 6112153
    [Abstract] [Full Text] [Related]

  • 15. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep 26; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 16. Interaction of pergolide with central dopaminergic receptors.
    Goldstein M, Lieberman A, Lew JY, Asano T, Rosenfeld MR, Makman MH.
    Proc Natl Acad Sci U S A; 1980 Jun 26; 77(6):3725-8. PubMed ID: 6932044
    [Abstract] [Full Text] [Related]

  • 17. Purification of the D-2 dopamine receptor from bovine striatum.
    Elazar Z, Kanety H, David C, Fuchs S.
    Biochem Biophys Res Commun; 1988 Oct 14; 156(1):602-9. PubMed ID: 2972288
    [Abstract] [Full Text] [Related]

  • 18. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    Poyner DR, Birdsall NJ, Curtis C, Eveleigh P, Hulme EC, Pedder EK, Wheatley M.
    Mol Pharmacol; 1989 Sep 14; 36(3):420-9. PubMed ID: 2506431
    [Abstract] [Full Text] [Related]

  • 19. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W.
    Arch Biochem Biophys; 1990 Feb 01; 276(2):424-32. PubMed ID: 2306106
    [Abstract] [Full Text] [Related]

  • 20. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE, Zaczek R, Pearsall DM, De Souza EB.
    Endocrinology; 1989 Dec 01; 125(6):3068-77. PubMed ID: 2555137
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.